Across the three
Skin outcomes, internal effects
A firmer-feeling face, a collagen measurement and an organ injury answer different questions. A useful comparison gives each its own space.
Reported outcomes
| Subject | What was observed | Scope of the result |
|---|---|---|
| GHK-Cu and collagen | Increased synthesis in human fibroblast cultures | Cells outside the body; a specific tissue-building response |
| Topical GHK-Cu | Procollagen response in small human studies | Reviewed skin findings, dependent on preparation and delivery |
| GHK with 5-aminolevulinic acid | Increased hair count in a controlled human trial | A combination preparation, leaving each ingredient's contribution unresolved |
| GLOW | No controlled clinical trial of the combination | Ingredient literature and a rationale; combined benefit and safety remain untested |
| Melanotan II | Pigment change and erectile response; serious case-reported harm | Small human trials alongside reports such as renal infarction |
Comfort, satisfaction and function
Reports of glow, firmness and confidence describe experiences that matter to the people having them. Community reports remain anecdotes rather than clinical evidence, and they cannot separate the substance's effect from everything else happening around it.
A measured increase in a precursor protein is a narrower finding. A hair-count increase in a 6-month trial is another sort of outcome again. I judge the comparison by whether those distinctions survive. An anti-ageing score would hide the very things needed to interpret it.
Route and risk
Topical cosmetic GHK-Cu has a longer history and more human skin research than its injected use. GLOW brings additional ingredients into an untested combined preparation. Melanotan II's kidney case concerns a different molecule and a serious internal injury. Those differences make a single safety ranking misleading.
The gap between the tested preparation and a proposed use determines how convincing I consider the claim. A skin-layer penetration experiment, a human cream study and an injection each create different questions about exposure. None of the compounds has FDA approval for the anti-ageing uses discussed on this site; the relevant uncertainties remain even when a result sounds attractive.